Deciphering the role of signal regulatory protein α in immunotherapy for solid tumors
{{output}}
Therapies targeting immune checkpoints like programmed death receptor-1 and programmed death ligand-1 have demonstrated remarkable effectiveness in combating cancer. However, a subset of patients fails to respond to these therapies, underscoring the complexity... ...
